nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceruletide—CCKAR—telencephalic ventricle—Parkinson's disease	0.19	0.394	CbGeAlD
Ceruletide—CCKAR—hindbrain—Parkinson's disease	0.0898	0.186	CbGeAlD
Ceruletide—CCKAR—brainstem—Parkinson's disease	0.0514	0.107	CbGeAlD
Ceruletide—CCKAR—forebrain—Parkinson's disease	0.0497	0.103	CbGeAlD
Ceruletide—CCKAR—head—Parkinson's disease	0.0284	0.0589	CbGeAlD
Ceruletide—CCKAR—nervous system—Parkinson's disease	0.027	0.0558	CbGeAlD
Ceruletide—CCKAR—central nervous system—Parkinson's disease	0.0259	0.0537	CbGeAlD
Ceruletide—CCKAR—brain—Parkinson's disease	0.0206	0.0427	CbGeAlD
Ceruletide—CCKAR—G alpha (q) signalling events—DGKQ—Parkinson's disease	0.0194	0.0375	CbGpPWpGaD
Ceruletide—CCKAR—Peptide ligand-binding receptors—GPR37—Parkinson's disease	0.0192	0.0371	CbGpPWpGaD
Ceruletide—CCKAR—Gastrin-CREB signalling pathway via PKC and MAPK—DGKQ—Parkinson's disease	0.0174	0.0336	CbGpPWpGaD
Ceruletide—CCKAR—GPCRs, Class A Rhodopsin-like—GPR37—Parkinson's disease	0.015	0.029	CbGpPWpGaD
Ceruletide—CCKAR—G alpha (q) signalling events—GRK5—Parkinson's disease	0.0147	0.0284	CbGpPWpGaD
Ceruletide—CCKAR—Gastrin-CREB signalling pathway via PKC and MAPK—GRK5—Parkinson's disease	0.0132	0.0254	CbGpPWpGaD
Ceruletide—CCKAR—Class A/1 (Rhodopsin-like receptors)—GPR37—Parkinson's disease	0.0129	0.0249	CbGpPWpGaD
Ceruletide—CCKAR—Peptide ligand-binding receptors—PENK—Parkinson's disease	0.0124	0.0239	CbGpPWpGaD
Ceruletide—CCKAR—Peptide ligand-binding receptors—PDYN—Parkinson's disease	0.0113	0.0218	CbGpPWpGaD
Ceruletide—CCKAR—G alpha (q) signalling events—GRM5—Parkinson's disease	0.0106	0.0206	CbGpPWpGaD
Ceruletide—CCKAR—GPCR ligand binding—GPR37—Parkinson's disease	0.00979	0.0189	CbGpPWpGaD
Ceruletide—CCKAR—Gastrin-CREB signalling pathway via PKC and MAPK—GRM5—Parkinson's disease	0.00951	0.0184	CbGpPWpGaD
Ceruletide—CCKAR—Class A/1 (Rhodopsin-like receptors)—PENK—Parkinson's disease	0.00828	0.016	CbGpPWpGaD
Ceruletide—CCKAR—G alpha (q) signalling events—TAC1—Parkinson's disease	0.00773	0.0149	CbGpPWpGaD
Ceruletide—CCKAR—Peptide ligand-binding receptors—TAC1—Parkinson's disease	0.00763	0.0148	CbGpPWpGaD
Ceruletide—CCKAR—Class A/1 (Rhodopsin-like receptors)—PDYN—Parkinson's disease	0.00758	0.0147	CbGpPWpGaD
Ceruletide—CCKAR—GPCRs, Class A Rhodopsin-like—ADORA2A—Parkinson's disease	0.00699	0.0135	CbGpPWpGaD
Ceruletide—CCKAR—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—Parkinson's disease	0.00691	0.0134	CbGpPWpGaD
Ceruletide—CCKAR—G alpha (q) signalling events—ADRBK1—Parkinson's disease	0.00685	0.0133	CbGpPWpGaD
Ceruletide—CCKAR—GPCR ligand binding—GRM4—Parkinson's disease	0.00665	0.0129	CbGpPWpGaD
Ceruletide—CCKAR—GPCR ligand binding—PENK—Parkinson's disease	0.00631	0.0122	CbGpPWpGaD
Ceruletide—CCKAR—Gastrin-CREB signalling pathway via PKC and MAPK—ADRBK1—Parkinson's disease	0.00613	0.0119	CbGpPWpGaD
Ceruletide—CCKAR—GPCRs, Class A Rhodopsin-like—HTR1A—Parkinson's disease	0.00607	0.0117	CbGpPWpGaD
Ceruletide—CCKAR—Class A/1 (Rhodopsin-like receptors)—ADORA2A—Parkinson's disease	0.00599	0.0116	CbGpPWpGaD
Ceruletide—CCKAR—GPCRs, Class A Rhodopsin-like—DRD1—Parkinson's disease	0.00586	0.0113	CbGpPWpGaD
Ceruletide—CCKAR—GPCR ligand binding—PDYN—Parkinson's disease	0.00577	0.0112	CbGpPWpGaD
Ceruletide—CCKAR—GPCRs, Class A Rhodopsin-like—DRD3—Parkinson's disease	0.00567	0.011	CbGpPWpGaD
Ceruletide—CCKAR—GPCR downstream signaling—DGKQ—Parkinson's disease	0.00553	0.0107	CbGpPWpGaD
Ceruletide—CCKAR—GPCR ligand binding—GRM5—Parkinson's disease	0.00536	0.0104	CbGpPWpGaD
Ceruletide—CCKAR—G alpha (q) signalling events—EDN1—Parkinson's disease	0.00531	0.0103	CbGpPWpGaD
Ceruletide—CCKAR—Peptide ligand-binding receptors—EDN1—Parkinson's disease	0.00525	0.0101	CbGpPWpGaD
Ceruletide—CCKAR—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.0052	0.0101	CbGpPWpGaD
Ceruletide—CCKAR—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.00513	0.00992	CbGpPWpGaD
Ceruletide—CCKAR—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.00513	0.00992	CbGpPWpGaD
Ceruletide—CCKAR—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.00512	0.0099	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—GPR37—Parkinson's disease	0.00502	0.00972	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—DGKQ—Parkinson's disease	0.00502	0.00972	CbGpPWpGaD
Ceruletide—CCKAR—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.00502	0.00971	CbGpPWpGaD
Ceruletide—CCKAR—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.00486	0.0094	CbGpPWpGaD
Ceruletide—CCKAR—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—Parkinson's disease	0.00475	0.00919	CbGpPWpGaD
Ceruletide—CCKAR—G alpha (q) signalling events—HTR2A—Parkinson's disease	0.00465	0.00899	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.00459	0.00889	CbGpPWpGaD
Ceruletide—CCKAR—GPCR ligand binding—ADORA2A—Parkinson's disease	0.00456	0.00882	CbGpPWpGaD
Ceruletide—CCKAR—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.0044	0.0085	CbGpPWpGaD
Ceruletide—CCKAR—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.0044	0.0085	CbGpPWpGaD
Ceruletide—CCKAR—GPCR downstream signaling—GRK5—Parkinson's disease	0.00419	0.00811	CbGpPWpGaD
Ceruletide—CCKAR—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Parkinson's disease	0.00416	0.00804	CbGpPWpGaD
Ceruletide—CCKAR—GPCR ligand binding—HTR1A—Parkinson's disease	0.00396	0.00765	CbGpPWpGaD
Ceruletide—CCKAR—GPCR ligand binding—TAC1—Parkinson's disease	0.0039	0.00754	CbGpPWpGaD
Ceruletide—CCKAR—GPCR ligand binding—DRD1—Parkinson's disease	0.00382	0.00739	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—GRK5—Parkinson's disease	0.00381	0.00736	CbGpPWpGaD
Ceruletide—CCKAR—GPCR downstream signaling—GRM4—Parkinson's disease	0.00376	0.00727	CbGpPWpGaD
Ceruletide—CCKAR—GPCR ligand binding—DRD3—Parkinson's disease	0.0037	0.00716	CbGpPWpGaD
Ceruletide—CCKAR—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.00359	0.00695	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—VPS35—Parkinson's disease	0.00358	0.00693	CbGpPWpGaD
Ceruletide—CCKAR—GPCR downstream signaling—PENK—Parkinson's disease	0.00356	0.00689	CbGpPWpGaD
Ceruletide—CCKAR—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.00352	0.00681	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—GRM4—Parkinson's disease	0.00341	0.0066	CbGpPWpGaD
Ceruletide—CCKAR—GPCR ligand binding—HTR7—Parkinson's disease	0.00335	0.00647	CbGpPWpGaD
Ceruletide—CCKAR—GPCR ligand binding—DRD2—Parkinson's disease	0.00335	0.00647	CbGpPWpGaD
Ceruletide—CCKAR—GPCR downstream signaling—PDYN—Parkinson's disease	0.00326	0.00631	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—PENK—Parkinson's disease	0.00324	0.00626	CbGpPWpGaD
Ceruletide—CCKAR—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.00308	0.00595	CbGpPWpGaD
Ceruletide—CCKAR—GPCR downstream signaling—GRM5—Parkinson's disease	0.00303	0.00586	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—GPR37—Parkinson's disease	0.00297	0.00574	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—DGKQ—Parkinson's disease	0.00297	0.00574	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—PDYN—Parkinson's disease	0.00296	0.00573	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—GRM5—Parkinson's disease	0.00275	0.00532	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—PPP1R1B—Parkinson's disease	0.00271	0.00525	CbGpPWpGaD
Ceruletide—CCKAR—GPCR ligand binding—EDN1—Parkinson's disease	0.00268	0.00518	CbGpPWpGaD
Ceruletide—CCKAR—GPCR downstream signaling—ADORA2A—Parkinson's disease	0.00258	0.00498	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—RIT2—Parkinson's disease	0.00237	0.00459	CbGpPWpGaD
Ceruletide—CCKAR—GPCR ligand binding—HTR2A—Parkinson's disease	0.00234	0.00453	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—ADORA2A—Parkinson's disease	0.00234	0.00453	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—GRK5—Parkinson's disease	0.00225	0.00435	CbGpPWpGaD
Ceruletide—CCKAR—GPCR downstream signaling—HTR1A—Parkinson's disease	0.00224	0.00432	CbGpPWpGaD
Ceruletide—CCKAR—GPCR downstream signaling—TAC1—Parkinson's disease	0.0022	0.00426	CbGpPWpGaD
Ceruletide—CCKAR—GPCR downstream signaling—DRD1—Parkinson's disease	0.00216	0.00418	CbGpPWpGaD
Ceruletide—CCKAR—GPCR downstream signaling—DRD3—Parkinson's disease	0.00209	0.00405	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—HTR1A—Parkinson's disease	0.00203	0.00393	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—GRM4—Parkinson's disease	0.00202	0.0039	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—TAC1—Parkinson's disease	0.002	0.00387	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—DRD1—Parkinson's disease	0.00196	0.00379	CbGpPWpGaD
Ceruletide—CCKAR—GPCR downstream signaling—ADRBK1—Parkinson's disease	0.00195	0.00378	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—PENK—Parkinson's disease	0.00191	0.0037	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—MAG—Parkinson's disease	0.00191	0.0037	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—DRD3—Parkinson's disease	0.0019	0.00367	CbGpPWpGaD
Ceruletide—CCKAR—GPCR downstream signaling—DRD2—Parkinson's disease	0.00189	0.00366	CbGpPWpGaD
Ceruletide—CCKAR—GPCR downstream signaling—HTR7—Parkinson's disease	0.00189	0.00366	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—ADRBK1—Parkinson's disease	0.00177	0.00343	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—PDYN—Parkinson's disease	0.00175	0.00338	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—DRD2—Parkinson's disease	0.00172	0.00332	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—HTR7—Parkinson's disease	0.00172	0.00332	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—GFAP—Parkinson's disease	0.00164	0.00318	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—GRM5—Parkinson's disease	0.00163	0.00314	CbGpPWpGaD
Ceruletide—CCKAR—GPCR downstream signaling—EDN1—Parkinson's disease	0.00151	0.00293	CbGpPWpGaD
Ceruletide—CCKAR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Parkinson's disease	0.00144	0.00279	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—FGF20—Parkinson's disease	0.00143	0.00276	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—ADORA2A—Parkinson's disease	0.00138	0.00267	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—EDN1—Parkinson's disease	0.00138	0.00266	CbGpPWpGaD
Ceruletide—CCKAR—GPCR downstream signaling—HTR2A—Parkinson's disease	0.00132	0.00256	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—INSR—Parkinson's disease	0.00128	0.00247	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—FGB—Parkinson's disease	0.00121	0.00233	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—HTR2A—Parkinson's disease	0.0012	0.00233	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—HTR1A—Parkinson's disease	0.0012	0.00232	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—TAC1—Parkinson's disease	0.00118	0.00228	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—DRD1—Parkinson's disease	0.00116	0.00224	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—DRD3—Parkinson's disease	0.00112	0.00217	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—ADRBK1—Parkinson's disease	0.00105	0.00203	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—HTR7—Parkinson's disease	0.00101	0.00196	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—DRD2—Parkinson's disease	0.00101	0.00196	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—IGF2—Parkinson's disease	0.00085	0.00164	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—IGF1R—Parkinson's disease	0.000822	0.00159	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—EDN1—Parkinson's disease	0.000812	0.00157	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—NGF—Parkinson's disease	0.000747	0.00144	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—HTR2A—Parkinson's disease	0.000711	0.00137	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—APOE—Parkinson's disease	0.000661	0.00128	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—INS—Parkinson's disease	0.000565	0.00109	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—CASP3—Parkinson's disease	0.00042	0.000813	CbGpPWpGaD
Ceruletide—CCKAR—Signaling by GPCR—IL6—Parkinson's disease	0.000418	0.000808	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—MAPK8—Parkinson's disease	0.000386	0.000747	CbGpPWpGaD
Ceruletide—CCKAR—Signaling Pathways—IL6—Parkinson's disease	0.000247	0.000477	CbGpPWpGaD
